BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 15135926)

  • 1. Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans.
    Holzer P
    Neurosci Lett; 2004 May; 361(1-3):192-5. PubMed ID: 15135926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the potential role of methylnaltrexone in opioid bowel dysfunction.
    Foss JF
    Am J Surg; 2001 Nov; 182(5A Suppl):19S-26S. PubMed ID: 11755893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus.
    Neyens R; Jackson KC
    J Pain Palliat Care Pharmacother; 2007; 21(2):27-33. PubMed ID: 17844725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies.
    Kurz A; Sessler DI
    Drugs; 2003; 63(7):649-71. PubMed ID: 12656645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-induced side effects.
    Yuan CS
    J Support Oncol; 2004; 2(2):111-7; discussion 119-22. PubMed ID: 15328815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects.
    Yuan CS
    Ann Pharmacother; 2007 Jun; 41(6):984-93. PubMed ID: 17504835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain.
    Webster L; Jansen JP; Peppin J; Lasko B; Irving G; Morlion B; Snidow J; Pierce A; Mortensen E; Kleoudis C; Carter E
    Pain; 2008 Jul; 137(2):428-440. PubMed ID: 18164818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylnaltrexone bromide: new drug for the treatment of opioid-induced bowel dysfunction.
    Baker DE
    Rev Gastroenterol Disord; 2009; 9(3):E84-93. PubMed ID: 19898269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylnaltrexone: treatment for opioid-induced constipation.
    Licup N; Baumrucker SJ
    Am J Hosp Palliat Care; 2011 Feb; 28(1):59-61. PubMed ID: 20801917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid receptors in the gastrointestinal tract.
    Holzer P
    Regul Pept; 2009 Jun; 155(1-3):11-7. PubMed ID: 19345246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches to the treatment of opioid-induced constipation.
    Holzer P
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1(0 1):119-27. PubMed ID: 18924451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic treatment of opioid-induced constipation.
    Wang CZ; Yuan CS
    Expert Opin Investig Drugs; 2013 Oct; 22(10):1225-7. PubMed ID: 23834367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus.
    Becker G; Blum HE
    Lancet; 2009 Apr; 373(9670):1198-206. PubMed ID: 19217656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug approvals: '08 in review. Methylnaltrexone (Relistor).
    Laustsen G; Carrillo F; Johnson J; Smith C
    Nurse Pract; 2009 Feb; 34(2):31. PubMed ID: 19155882
    [No Abstract]   [Full Text] [Related]  

  • 15. [News from the cochrane library: mu opioid antagonists for opioid-induced bowel dysfunction].
    Meerpohl JJ; Timmer A
    Z Gastroenterol; 2008 Sep; 46(9):917-21. PubMed ID: 18810678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylnaltrexone: treatment for opioid-induced constipation--not convinced yet.
    HaiNan Liu ; Xiulu Ruan
    Am J Hosp Palliat Care; 2011 Jun; 28(4):290; author reply 291. PubMed ID: 21454318
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of methylnaltrexone in opioid-induced constipation.
    Hellwig TR; Pottebaum AA
    S D Med; 2013 Oct; 66(10):425, 427. PubMed ID: 24244983
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of opioid-induced gut dysfunction.
    Holzer P
    Expert Opin Investig Drugs; 2007 Feb; 16(2):181-94. PubMed ID: 17243938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Food and Drug Administration approves methylnaltrexone bromide for opioid-induced constipation.
    Lang L
    Gastroenterology; 2008 Jul; 135(1):6. PubMed ID: 18549816
    [No Abstract]   [Full Text] [Related]  

  • 20. Methylnaltrexone in treatment of opioid-induced constipation in a pediatric patient.
    Lee JM; Mooney J
    Clin J Pain; 2012 May; 28(4):338-41. PubMed ID: 21876436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.